Artemisinin and its derivatives exert antimalarial activity primarily through which mechanism?

Explanation

## Mechanism of Action of Artemisinin **Key Point:** Artemisinin and its derivatives (artesunate, artemether, dihydroartemisinin) are sesquiterpene lactones that generate **reactive oxygen species (ROS)** through interaction with parasite heme and iron, causing oxidative damage to parasite membranes and organelles. ## Molecular Basis 1. **Endoperoxide Bridge Activation:** The unique 1,2,4-trioxane ring in artemisinin is cleaved by parasite heme (Fe²⁺) and free iron. 2. **ROS Generation:** This cleavage produces carbon-centered radicals that react with oxygen to form ROS (superoxide, hydroxyl radicals). 3. **Cellular Damage:** ROS damages: - Parasite cell membrane (lipid peroxidation) - Mitochondrial membrane - Protein and DNA (secondary effect) ## Unique Features of Artemisinin Class | Feature | Detail | |---------|--------| | **Speed of action** | Fastest-acting antimalarial (parasite clearance in 24–48 hrs) | | **Efficacy** | Effective against all Plasmodium species, including resistant strains | | **Gametocidal** | Kills gametocytes, reducing transmission | | **Recrudescence risk** | High if used as monotherapy; always combine with partner drug (ACT) | | **Formulations** | Artesunate (IV/IM/PO), artemether (IM), dihydroartemisinin (PO) | **High-Yield:** Artemisinin-based combination therapies (ACTs) are the **WHO-recommended first-line treatment** for uncomplicated P. falciparum malaria globally. Examples: artesunate + amodiaquine, artesunate + lumefantrine. **Clinical Pearl:** Severe malaria (cerebral malaria, acute kidney injury, severe anemia) is treated with **IV artesunate** — the only drug shown to reduce mortality in severe malaria (SEAQUAMAT trial). ## Why Not Monotherapy? Artemisinin derivatives have a short half-life (1–3 hours). Monotherapy leads to: - Incomplete parasite clearance - High recrudescence rates (up to 50%) - Selection of artemisinin-resistant parasites **Mnemonic:** **ART = Artemisinin Reactive Oxygen Therapy** — remember ROS generation as the core mechanism.